Is Bunge Global (BG) a risky stock?
As of July 21, 2026, Clavix grades Bunge Global (BG) B+ for risk, a composite score of 73 out of 100 on an A+ to F scale, which puts BG in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind BG's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how BG scores on each, as of July 21, 2026.
What's moving BG's risk right now
Company-specific signals Clavix flags behind BG's current grade, drawn from recent news and filings as of July 21, 2026.
Aldebaran Capital cut its BG position by 28.1% in Q1, according to its latest 13F filing. The only other recent items were a routine sector-comparison article and a standard SEC 8-K filing, offering no clear catalyst.
Wall Street brokerages rate BG a consensus 'Moderate Buy,' suggesting steady rather than exceptional upside. The stock has already risen 78% over five years, so high expectations leave little room for an earnings miss.
Bunge is folding Viterra into its operations, scaling its worldwide infrastructure for grains and oilseeds. If the expected synergies come through, the combined business could grow revenue capacity and market share.
What a B+ grade means
On the Clavix A+ to F scale, BG's composite of 73 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell BG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.